BLSM Stock Chart & Stats
$22.93
$0.92(4.18%)
―
--
Day’s Range― - ―
52-Week Range$15.25 - $23.37
Previous CloseN/A
VolumeN/A
Average Volume (3M)284.92K
Market Cap
$674.47M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta5.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,643,660
10 Day Avg. Volume128,963
30 Day Avg. Volume284,921
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$31.25Price Target Upside― Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BlossomHill Therapeutics, Inc. News
BLSM FAQ
What was BlossomHill Therapeutics, Inc.’s price range in the past 12 months?
BlossomHill Therapeutics, Inc. lowest stock price was $15.25 and its highest was $23.37 in the past 12 months.
What is BlossomHill Therapeutics, Inc.’s market cap?
BlossomHill Therapeutics, Inc.’s market cap is $674.47M.
When is BlossomHill Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BlossomHill Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is BlossomHill Therapeutics, Inc. overvalued?
According to Wall Street analysts BlossomHill Therapeutics, Inc.’s price is currently Undervalued.
Does BlossomHill Therapeutics, Inc. pay dividends?
BlossomHill Therapeutics, Inc. does not currently pay dividends.
What is BlossomHill Therapeutics, Inc.’s EPS estimate?
BlossomHill Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BlossomHill Therapeutics, Inc. have?
BlossomHill Therapeutics, Inc. has 30,643,660 shares outstanding.
What happened to BlossomHill Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BlossomHill Therapeutics, Inc.?
Currently, no hedge funds are holding shares in BLSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BlossomHill Therapeutics, Inc. Stock Smart Score
Company Description
BlossomHill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.